ArticleCochrane evidence synthesis and methods2025
Human Versus Artificial Intelligence: Comparing Cochrane Authors' and ChatGPT's Risk of Bias Assessments.
Article in Cochrane evidence synthesis and methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Performance and Consistency of Large Language Models in Key Labor-Intensive Tasks of Systematic Reviews.Journal of evaluation in clinical practice · 2026Article
- Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study.Scientific reports · 2026Article
- Not Ready for Prime Time: Limitations of a Retrieval-Augmented Generation Large Language Model in Assessing Risk of Bias in Observational Studies.Journal of the Pediatric Orthopaedic Society of North America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Systematic reviews and meta-analyses synthesize randomized trial data to guide clinical decisions but require significant time and resources. Artificial intelligence (AI) offers a promising solution to streamline evidence synthesis, aiding study selection, data extraction, and risk of bias assessment. This study aims to evaluate the performance of ChatGPT-4o in assessing the risk of bias in randomised controlled trials (RCTs) using the Risk of Bias 2 (RoB 2) tool, comparing its results with those conducted by human reviewers in Cochrane Reviews. Methods: A sample of Cochrane Reviews utilizing the RoB 2 tool was identified through the Cochrane Database of Systematic Reviews (CDSR). Protocols, qualitative systematic reviews, and reviews employing alternative risk of bias assessment tools were excluded. The study utilized ChatGPT-4o to assess the risk of bias using a structured set of prompts corresponding to the RoB 2 domains. The agreement between ChatGPT-4o and consensus-based human reviewer assessments was evaluated using weighted kappa statistics. Additionally, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were calculated. All analyses were performed using R Studio (version 4.3.0). Results: A total of 42 Cochrane Reviews were screened, yielding a final sample of eight eligible reviews comprising 84 RCTs. The primary outcome of each included review was selected for risk of bias assessment. ChatGPT-4o demonstrated moderate agreement with human reviewers for the overall risk of bias judgments (weighted kappa = 0.51, 95% CI: 0.36-0.66). Agreement varied across domains, ranging from fair ( Conclusion: This study shows that ChatGPT-4o can perform risk of bias assessments using RoB 2 with fair to moderate agreement with human reviewers. While AI-assisted risk of bias assessment remains imperfect, advancements in prompt engineering and model refinement may enhance performance. Future research should explore standardised prompts and investigate interrater reliability among human reviewers to provide a more robust comparison.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.